Effects of a Ketogenic Diet on [18F]FDG-PET Imaging in a Mouse Model of Lung Cancer
- 568 Downloads
Myocardial uptake can hamper visualization of lung tumors, atherosclerotic plaques, and inflammatory diseases in 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) studies because it leads to spillover in adjacent structures. Several preparatory pre-imaging protocols (including dietary restrictions and drugs) have been proposed to decrease physiological [18F]FDG uptake by the heart, although their effect on tumor glucose metabolism remains largely unknown. The objective of this study was to assess the effects of a ketogenic diet (as an alternative protocol to fasting) on tumor glucose metabolism assessed by [18F]FDG positron emission tomography (PET) in a mouse model of lung cancer.
PET scans were performed 60 min after injection of 18.5 MBq of [18F]FDG. PET data were collected for 45 min, and an x-ray computed tomograph (CT) image was acquired after the PET scan. A PET/CT study was obtained for each mouse after fasting and after the ketogenic diet. Quantitative data were obtained from regions of interest in the left ventricular myocardium and lung tumor.
Three days on a ketogenic diet decreased mean standard uptake value (SUVmean) in the myocardium (SUVmean 0.95 ± 0.36) more than one night of fasting (SUVmean 1.64 ± 0.93). Tumor uptake did not change under either dietary condition.
These results show that 3 days on high-fat diets prior to [18F]FDG-PET imaging does not change tumor glucose metabolism compared with one night of fasting, although high-fat diets suppress myocardial [18F]FDG uptake better than fasting.
Key wordsHigh-fat diet [18F]FDG-PET Ketogenic diet Fasting Lung cancer
The authors thank Alexandra de Francisco and Yolanda Sierra for their excellent work with animal preparation and imaging protocols.
This work was partially supported by Comunidad de Madrid (S2017/BMD-3867 RENIM-CM) and cofinanciado con Fondos Estructurales de la Unión Europea. The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
Compliance with Ethical Standards
All animal procedures were approved by the Animal Experimentation Ethics Committee of Hospital General Universitario Gregorio Marañón (ES280790000087) and the Ethics Committees of CNIO and the Carlos III Health Institute, Madrid, and performed according to European regulations (2010/63/UE) and National regulations (RD 53/2013).
Conflict of Interest
The authors declare that they have no conflicts of interest.
- 4.Fallahi B, Moasses-Ghafari B, Fard-Esfahani A et al (2017) Factors influencing the pattern and intensity of myocardial 18F-FDG uptake in oncologic PET-CT imaging. Iranian J Nucl Med 25:52–61Google Scholar
- 9.Tupper T, Wang Y, McDonagh E, et al. (2011) Utilizing Ketogenic Diet as an Alternative to Fasting in Preclinical 18F-FDG PET. In World Mol Imaging Congress (WMIC): 2011 Program BookGoogle Scholar
- 20.Ambrogio C, Cámara JA, Nieto P et al (2015) Analysis of murine lung tumors by micro PET-CT imaging. In Bio-protocol:e1692Google Scholar
- 21.Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R (2009) Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 50:563–568CrossRefGoogle Scholar
- 22.Bertagna F, Bisleri G, Motta F, Merli G, Cossalter E, Lucchini S, Biasiotto G, Bosio G, Terzi A, Muneretto C, Giubbini R (2012) Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging 28:1417–1425CrossRefGoogle Scholar
- 24.Wang Y, Seidel J, Tsui BMW, Vaquero JJ, Pomper MG (2006) Performance evaluation of the GE Healthcare eXplore VISTA dual-ring small-animal PET scanner. J Nucl Med 47:1891–1900Google Scholar
- 26.Huebbers CU, Adam AC, Preuss SF, Schiffer T, Schilder S, Guntinas-Lichius O, Schmidt M, Klussmann JP, Wiesner RJ (2015) High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial β-F1-ATPase subunit in head and neck squamous cell carcinoma. Oncotarget 6:36172–36184CrossRefGoogle Scholar
- 27.Guckenberger M, Rudofsky L, Andratschke N (2015) FDG-PET imaging for advanced radiotherapy treatment of non-small-cell lung Cancer. In: Hodler J, von Schulthess GK, Kubik-Huch RA, Zollikofer CL (eds) Diseases of the chest and heart 2015–2018. Springer Milan, pp 177–182Google Scholar
- 29.Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H (1993) Influence of the blood glucose concentration on FDG uptake in Cancer—a PET study. J Nucl Med 34:1–6Google Scholar
- 41.Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269–270Google Scholar
- 42.Langen KJ, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, Feinendegen LE (1993) The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 34:355–359Google Scholar
- 45.Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA (2006) Impact of animal handling on the results of 18FDG PET studies in mice. J Nucl Med 47:999–1006Google Scholar